2. Cell Cycle/DNA Damage Epigenetics Metabolic Enzyme/Protease Immunology/Inflammation NF-κB Apoptosis MAPK/ERK Pathway Stem Cell/Wnt TGF-beta/Smad Protein Tyrosine Kinase/RTK JAK/STAT Signaling Cytoskeleton
  3. PARP Reactive Oxygen Species (ROS) Apoptosis NF-κB ERK Bcl-2 Family TGF-β Receptor EGFR Cadherin
  4. Theophylline-platinum(IV) prodrug-1

Theophylline-platinum(IV) prodrug-1 is a PARP-1 inhibitor. Theophylline-platinum(IV) prodrug-1 enhances DNA damage, ROS production, mitochondrial dysfunction, apoptosis and S-phase arrest, along with reducing invasion and metastasis in SKOV3-BRCA1-KD cells. Theophylline-platinum(IV) prodrug-1 exhibits superior antitumor activity in the xenograft SKOV3-BRCA1-KD tumor model. Theophylline-platinum(IV) prodrug-1 can be used for the study of ovarian cancer.

For research use only. We do not sell to patients.

Theophylline-platinum(IV) prodrug-1

Theophylline-platinum(IV) prodrug-1 Chemical Structure

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Theophylline-platinum(IV) prodrug-1 Related Antibodies

Top Publications Citing Use of Products

View All PARP Isoform Specific Products:

View All Isoforms
PARP PARP1 PARP2 PARP3 PARP4 TNKS1/PARP5A TNKS2/PARP5B PARP7 PARP10 PARP14 PARP15 PARP12 PARP16

View All NF-κB Isoform Specific Products:

View All Isoforms
NF-κB NF-κB1/p50 RelA/p65 RelB c-Rel

View All ERK Isoform Specific Products:

View All Isoforms
ERK ERK1 ERK2 ERK5 ERK8

View All Bcl-2 Family Isoform Specific Products:

View All Isoforms
Bcl-2 Bcl-xL Bcl-W Mcl-1 Bfl-1 Bcl-B Bax Bak Bim BNIP3

View All TGF-β Receptor Isoform Specific Products:

View All Isoforms
ALK1 ALK2 ALK3 ALK4 ALK5 ALK6 ALK7 TGFβR2 ACVR2A ACVR2B

View All EGFR Isoform Specific Products:

View All Isoforms
EGFR/ErbB1/HER1 ErbB2/HER2 ErbB3/HER3 ErbB4/HER4

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

Theophylline-platinum(IV) prodrug-1 is a PARP-1 inhibitor. Theophylline-platinum(IV) prodrug-1 enhances DNA damage, ROS production, mitochondrial dysfunction, apoptosis and S-phase arrest, along with reducing invasion and metastasis in SKOV3-BRCA1-KD cells. Theophylline-platinum(IV) prodrug-1 exhibits superior antitumor activity in the xenograft SKOV3-BRCA1-KD tumor model. Theophylline-platinum(IV) prodrug-1 can be used for the study of ovarian cancer[1].

In Vitro

Theophylline-platinum(IV) prodrug-1 (Compound 4) (10-10-10-3 μM, 72 h) inhibits the proliferation of SKOV3 cells (IC50 = 0.13 μM), SKOV3-BRCA1-KD cells (IC50 = 0.1 μM), A549 cells (IC50 = 0.31 μM), A549-BRCA1-KD cells (IC50 = 0.18 μM), MCF-7 cells (IC50 = 0.10 μM), MCF-7-BRCA1-KD cells (IC50 = 0.04 μM), MDA-MB-231 cells (IC50 = 0.08 μM), IOSE-80 cells (IC50 = 0.18 μM) and SI cells (IC50 = 18 μM)[1].
Theophylline-platinum(IV) prodrug-1 (10 μM, 6 h) induces DNA damage in SKOV3 and SKOV3-BRCA1-KD cells[1].
Theophylline-platinum(IV) prodrug-1 (0.5-2 μM, 24 h) induces ROS production, mitochondrial membrane potential damage, cell cycle arrest and apoptosis in SKOV3 and SKOV3-BRCA1-KD cells[1].
Theophylline-platinum(IV) prodrug-1 (0.5 μM, 24 h) induces invasion and metastasis inhibition in SKOV3 and SKOV3-BRCA1-KD cells[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Theophylline-platinum(IV) prodrug-1 Related Antibodies

Immunofluorescence[1]

Cell Line: SKOV3 and SKOV3-BRCA1-KD cells
Concentration: 0.5, 1, 10 μM
Incubation Time: 6, 24 h
Result: Induced a remarkable 15.13-fold increase in γH2AX foci formation in SKOV3-BRCA1-KD cells.
Showed a 4.45-fold increase in the olive tail moment compared to Cisplatin (HY-17394) in BRCA1-deficient cells.
Resulted in larger and more intense foci, suggesting a more severe and potentially irreparable form of DNA damage.
Induced ROS effects in BRCA1-deficient cells particularly.
Showed the most significant effect on MMP in both cell lines, with the effect being more pronounced in SKOV3-BRCA1-KD cells.

Cell Cycle Analysis[1]

Cell Line: SKOV3 and SKOV3-BRCA1-KD cells
Concentration: 1 μM
Incubation Time: 24 h
Result: Resulted in an S-phase cell proportion of 38.67% in SKOV3 cells and led to an S-phase cell proportion of 63.52% in BRCA1-deficient cells.
Showed S-phase arrest in BRCA1-deficient cells.

Apoptosis Analysis[1]

Cell Line: SKOV3 and SKOV3-BRCA1-KD cells
Concentration: 2 μM
Incubation Time: 24 h
Result: Showed particularly notable apoptosis induction effects in SKOV3 and SKOV3-BRCA1-KD cells.
Exhibited an even more striking effect on SKOV3 cells, inducing apoptosis in 25.7% of the population.

Immunofluorescence[1]

Cell Line: SKOV3 and SKOV3-BRCA1-KD cells
Concentration: 1 μM
Incubation Time: 15 h
Result: Decreased PARP-1 levels in SKOV3-BRCA1-KD cells.
Upregulated γH2AX levels particularly in BRCA1-deficient cancer cells.
Enhanced the pro-apoptotic protein Bax levels and suppressed the antiapoptotic protein Bcl-2 levels.
Downregulated NF-κB, TGF-β, Smad2, EGFR and E-cadherin levels.
Increased the expression of N-cadherin and vimentin.
In Vivo

Theophylline-platinum(IV) prodrug-1 (Compound 4) (2.5 mg/kg, i.v., every three days for a total of six doses) exhibits superior antitumor activity in the xenograft SKOV3-BRCA1-KD tumor model[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Female BALB/c-nude mice using a cell-derived xenograft (CDX) SKOV3-BRCA1-KD tumor model[1]
Dosage: 2.5 mg/kg
Administration: i.v. every three days for a total of six doses
Result: Inhibited tumor growth by 71.70%.
Maintained stable body weights.
Showed no significant changes in any of these hematological parameters.
Exhibited a near-normal morphology, similar to that of the control group.
Reduced PARP-1 protein expression.
Molecular Weight

792.66

Formula

C25H46Cl2N6O6Pt
SMILES

[NH3][Pt+4]([NH3])([O-]C(CN1C=NC(N(C(N2C)=O)C)=C1C2=O)=O)([O-]C(CCCCCCCCCCCCCCC)=O)([Cl-])[Cl-]
Shipping

Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

Theophylline-platinum(IV) prodrug-1 Related Classifications

  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

Theophylline-platinum(IV) prodrug-1PARPReactive Oxygen Species (ROS)ApoptosisNF-κBERKBcl-2 FamilyTGF-β ReceptorEGFRCadherinpoly ADP ribose polymerase Nuclear factor-κBNuclear factor-kappaBExtracellular signal regulated kinasesTransforming growth factor beta receptorsEpidermal growth factor receptorErbB-1HER1ROSNF-KBapoptosisovarian cancerSKOV3-BRCA1-KD cellsInhibitorinhibitorinhibit

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

  

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

      

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Theophylline-platinum(IV) prodrug-1
Cat. No.:
HY-175257
Quantity:
MCE Japan Authorized Agent:

Customer Review

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

Product Name

  

Lot #

Applicant Name *

 

Email Address *

Phone Number

 

Department *

Organization Name *

 

Country or Region *

Remarks

SAFETY DATA SHEET (SDS)

Request for HNMR Report

We have received your request and will respond to you as soon as possible.